View by type:
Articles (4215)
In less than a year, the world has come together to develop effective COVID-19 vaccines and a multilateral platform for allocating them most efficiently around the world. But with the risk of vaccine nationalism still looming large, now is the…
What do the new COVID-19 variants mean for vaccine development?
Viruses are constantly mutating and often this process does not have any impact on the risk they pose to humans. However, occasionally mutations can occur which make it easier for viruses to infect us, or which could render vaccines against them…
Long-lasting symptoms appear unrelated to how bad your infection was, though women appear more affected than men.
What you need to know about a COVID-19 vaccine
Answers to the most common questions about coronavirus vaccine development.
Managing Well in the Work-From-Home Era
Managers owe it to their employees to stop treating work from home like a luxury. The office wasn’t invited into the home. It turned up like an unexpected guest – and it shows few signs of leaving soon.
What are whole virus vaccines and how could they be used against COVID-19?
Whole virus vaccines use a weakened or deactivated version of the disease-causing virus to trigger protective immunity against it.
Seven vital questions about RNA Covid-19 vaccines
The Pfizer-BioNTech and Moderna Covid-19 vaccines are more than 90% effective, as reported in phase III clinical trials – and the Pfizer-BioNTech vaccine is the first Covid-19 vaccine to be licensed.
What are viral vector-based vaccines and how could they be used against COVID-19?
Viral vector-based vaccines use a harmless virus to smuggle the instructions for making antigens from the disease-causing virus into cells, triggering protective immunity against it.
How close are we to a ‘workable’ HIV vaccine?
Despite huge advancements in the treatment and prevention of HIV/AIDS in recent decades, an effective vaccine remains elusive – and is desperately needed to end the global pandemic that kills more than 700,000 people each year.
Severe COVID may be caused by 'autoantibodies' – here is what that means
Antibodies that go rogue and attack healthy tissue identified in patients with severe COVID.
The United States has approved US$ 4 billion for Gavi, the Vaccine Alliance to ensure lower-income economies have equitable access to safe and effective COVID-19 vaccines on the same urgent timeline as wealthier countries.
What are protein subunit vaccines and how could they be used against COVID-19?
Protein subunit vaccines use fragments of protein from the disease-causing virus to trigger protective immunity against it.